Next Article in Journal
Characterisation of Gas-Chromatographic Poly(Siloxane) Stationary Phases by Theoretical Molecular Descriptors and Prediction of McReynolds Constants
Next Article in Special Issue
Nutritional Factors, DNA Methylation, and Risk of Type 2 Diabetes and Obesity: Perspectives and Challenges
Previous Article in Journal
Experiments with Snails Add to Our Knowledge about the Role of aPKC Subfamily Kinases in Learning
Previous Article in Special Issue
The Impact of Caloric Restriction on the Epigenetic Signatures of Aging
Open AccessReview

Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome

Department of Pediatrics, San Paolo Hospital, University of Milan, Via A. Di Rudinì 8, I - 20142 Milan, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(9), 2118; https://doi.org/10.3390/ijms20092118
Received: 28 February 2019 / Revised: 12 April 2019 / Accepted: 25 April 2019 / Published: 29 April 2019
(This article belongs to the Special Issue Nutrition, Epigenetics, and Diseases)
Childhood obesity represents an important public health issue worldwide and is strongly linked to metabolic alterations such as hypertension, insulin resistance, and dyslipidemia. The constellation of these conditions is commonly known as Metabolic Syndrome (MetS). Metabolic syndrome is not just a simple cluster of metabolic complications due to excess of adipose tissue, but is considered a risk factor for cardiovascular diseases. Evidence from several human and animal studies suggests that environmental and nutritional exposure during pregnancy may affect the newborn development and future health through epigenetic changes, playing a potential role in determining obesity and obesity-related complications. Understanding how nutritional epigenetic mechanisms contribute to the “transgenerational risk” for obesity and metabolic dysfunction is crucial in order to develop early prevention strategies for children’s health. Nutrigenetics is the science that studies the role of nutrients in gene expression. Long Chain Polyunsaturated Fatty Acids (LCPUFAs) are known for their health benefits, especially in relation to their ability to modulate inflammation and improve some obesity-associated comorbidities, mainly by decreasing plasma triglycerides. Recent nutrigenetic research is focusing on the potential role of LCPUFAs in influencing epigenetic markers. In this review, we present the most recent updates about the possible interaction between n-3 LCPUFAs and epigenetic pathways in metabolic syndrome. Literature from MEDLINE® and the Cochrane database between May 2005 and December 2018 has been scanned. View Full-Text
Keywords: DHA; LCPUFAs; pediatric obesity; metabolic syndrome; epigenetics; nutritional programming DHA; LCPUFAs; pediatric obesity; metabolic syndrome; epigenetics; nutritional programming
MDPI and ACS Style

Amatruda, M.; Ippolito, G.; Vizzuso, S.; Vizzari, G.; Banderali, G.; Verduci, E. Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome. Int. J. Mol. Sci. 2019, 20, 2118.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop